We hope you’re having a great February and looking forward to spending some quality time with your family and friends this weekend!
As the API network and team continues to grow by way of industry and academic collaborations, this newsletter serves as a medium for us to share our latest company and ecosystem updates with you. This month was particularly more significant for us as we strengthen our presence at key advocacy groups, community building events and participated in discussions to build a more healthy and vibrant life sciences community.
Continue to scroll down to read about what we’ve been up to this month!
If you’ve been enjoying receiving these updates and feel that others in your network could find this information valuable, we encourage you to share this with them. Additionally, if you’re interested in working with us as a network member, client, or trainee, you can contact us at email@example.com, or reach out on Twitter and Linkedin.
Take good care until next time,
The API Team
API joins the Canadian Chamber of Commerce
API has joined the the Canadian Chamber of Commerce. We are thrilled to join their Canadian Life Sciences Strategy Council and connect with other national ecosystem leaders to discuss the federal biomanufacturing and life sciences strategy implementation in order to better strengthen the industry in Canada.
Bringing Value for Entrepreneurs through Collaborations: Health and Tech
API’s CEO Andrew MacIsaac participated in the panel discussion at the February Rainforest Connector organized by Rainforest Alberta-YEG. The event featured industry collaborations and centres that are providing value as innovation system catalysts and growth agents for biotechnology, health and technology entrepreneurs.
Andrew MacIsaac, CEO at API was a guest on ‘Telling it Like it is’ show to talk about the Life Sciences start-up ecosystem within Alberta and Canada, the opportunities available for them to network and raise funds, and raised awareness about API’s platform, and how API is helping start-ups commercialize their ideas and scale up within Canada.
|People of API
Archana Koul, Scientist, API: Interacting with Industry
API’s industry model, combined with hands-on training & mentorship by academic and industry experts helps graduates and post-doctoral fellows become better prepared for a career in the Life Sciences industry.
In this video, Archana Koul, Scientist (S1) shares her experience of working with API as a post-doctoral fellow, and how this experience allowed her to interact with industry partners and gain practical skills.
The API Palette
API hosted a ‘Virtual Paint and Connect’ event – our first employee team building activity for this year. We’re so excited to share these amazing Wild Poppies masterpieces created by some of our team. A special thank you to the team at Vin Gogh Studio from Calgary, AB for helping us plan this evening and helping all of us at API connect with our inner artists!
|Upcoming Events and Opportunities
Startup TNT Life Sciences Investment Summit FINALE
API and Startup TNT have partnered to co-create this summit with a goal to raise over $1,000,000 in private capital for life sciences start-ups. As part of this summit, we recently co-hosted the Top 20 Pitch Night, the first event for this summit that received an overwhelmingly positive response and unique viewers!
The Summit Finale will be our next and final event on March 17th. We hope that you will continue supporting us with your participation at this event as well.
Click below to see more details and register for the event.
ACCEPTING APPLICATIONS: Life Sciences SME Market Access Program
The Institute of Health Economics (IHE) is currently accepting applications for their Life Sciences SME Market Access Program. Interested Life Sciences SMEs and Startups in Western Canada can now submit an Expression of Interest by March 1, 2022.
|Local Life Science & Innovation News
Nobel Prize Winner, Dr. Michael Houghton of University of Alberta and the Li Ka Shing Applied Virology Institute (LKSAVI) was interviewed by TheFutureEconomy.ca to talk about Alberta’s life science potential to become a key driver of the Canadian economy.
An Alberta-developed drug heralded as a potential oral treatment for COVID-19 has begun testing at Edmonton’s University of Alberta hospital.
Innovate Edmonton has selected a new public space for operations, program delivery, co-working and events to open in Fall 2022.
To view the online version of the newsletter and subscribe, click the below link: https://mailchi.mp/appliedpharma/february-2022-newsletter-5111193